Salivary gland-type cancers: cross-organ demographics of a rare cancer

By Aika Tanzawa, Kengo Saito, Masayuki Ota, Koji Takahashi, Izumi Ohno, T. Hanazawa, K. Uzawa, Yuichi Takiguchi. 2024

Subfields: Epidemiology, Oncology, Otorhinolaryngology

Citations in the corpus

• Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland Carcinomas (2026, unknown): “SGCs pose a significant clinical challenge due to their rarity, heterogeneous histological characteristics, and aggressive clinical behavior [5].”